Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Strategies for Treatment-Experienced HIVersStrategies for Treatment-Experienced HIVers
          
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


Earliest
Oct 19, 2006

What is the earliest that we should have a single pill with minimal complications and Hiv turns to history as far as possible

z

Response from Dr. Daar

The good news is that we already have very simple to take, and often well tolerated medications for the treatment of HIV infection. In fact, recently a single pill became available that is highly effective in the treatment of HIV infection. It is a combination of the medications tenofovir (Viread), emtricitabine (FTC, Emtriva), and efavirenz (Sustiva) called "Atripla." It is not for everyone and can have side effects, but for many starting therapy for the first time it is well tolerated and highly effective. I would encourage you and anyone else considering HIV therapy to talk to their provider to see if this or other options would be best. While many people will control their HIV infection with this and other medications, they are not a cure.

Best, Eric


Previous
CD4
Next
New Medication

  
  • Email Email
  • Glossary Glossary


 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement